Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Insmed
AddedMar 19, 2024
UpdatedJul 9, 2026
Insmed

Insmed

Public

Biopharmaceutical company in Bridgewater, NJ, transforming lives of patients with serious diseases.

HQ
Bridgewater Township, NJ, US
Founded
1999
Overview
Compare
Fundraising
Employees
Website

Insmed Incorporated, founded in Bridgewater, New Jersey, is a biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases. Their core mission is to develop and commercialize innovative therapies that address unmet medical needs. Insmed offers ARIKAYCE for treating Mycobacterium avium complex lung disease and is developing Brensocatib for bronchiectasis, cystic fibrosis, and other neutrophil-mediated diseases. The company focuses on providing life-changing solutions for patients globally.

Notable figures associated with Insmed include its leadership team and key investors who support its mission to advance medical science. The company has achieved significant milestones, including the successful commercialization of ARIKAYCE and ongoing clinical trials for Brensocatib. Insmed's impact is profound, as it continues to make a difference in the lives of patients worldwide through its commitment to daring science and a collaborative culture.

Insmed - Similar Companies

Pulmatrix logo

Pulmatrix

pulmatrix.com

MediciNova logo

MediciNova

medicinova.com

MannKind logo

MannKind

mannkindcorp.com

Bristol Myers Squibb logo

Bristol Myers Squibb

bms.com

Amphastar Pharmaceuticals logo

Amphastar Pharmaceuticals

amphastar.com

Vertex Pharmaceuticals logo

Vertex Pharmaceuticals

vrtx.com

Intellimedix logo

Intellimedix

Inception Sciences logo

Inception Sciences

Theravance Biopharma logo

Theravance Biopharma

theravance.com

Assertio Holdings logo

Assertio Holdings

Medinox logo

Medinox

medinox.com

Innovation Pharmaceuticals logo

Innovation Pharmaceuticals

ipharminc.com

Complexa logo

Complexa

HI-Bio logo

HI-Bio

hibio.com

Bridge Medicines logo

Bridge Medicines

Insmed - Quick Facts

Who are Insmed's competitors?

Companies similar to Insmed include Pulmatrix, MediciNova, MannKind and Bristol Myers Squibb.

When was Insmed founded?

Insmed was founded in 1999.

Where is Insmed's headquarters located?

Insmed's headquarters is located in Bridgewater Township, NJ, US.

When was Insmed's last funding round?

Insmed's most recent funding round was for $500k (USD) in May 2023.

How much has Insmed raised to-date?

As of May 8, 2023, Insmed has raised a total of $3B (USD).

How many employees does Insmed have?

Insmed has 736 employees as of Feb 6, 2024.

Insmed - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Therapeutics
Tags
  • Biotech
  • Healthcare
  • Healthtech
Unique IDs
  • ein: 541972729
  • secCik: 0001104506
  • ticker: INSM
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering